SCHEMBL5685447

SCHEMBL5685447

Fc1ccc(Sc2cc[c]cc2)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 6/20 0.40
KMT2A Q03164 6/20 0.40
MAPT P10636 2/20 0.40
CYP1A2 P05177 2/20 0.39
CYP2C9 P11712 1/20 0.39
CYP2C19 P33261 1/20 0.39
NR1H2 P55055 1/20 0.36
CYP3A4 P08684 1/20 0.36
TSHR P16473 1/20 0.36
MAPK1 P28482 1/20 0.36
NPSR1 Q6W5P4 2/20 0.36
ALDH1A1 P00352 2/20 0.34
HTT P42858 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
MAOA P21397 3/20 0.33
MAOB P27338 3/20 0.33
POLB P06746 1/20 0.33
PTPN1 P18031 1/20 0.33
CDC25A P30304 1/20 0.33
CDC25B P30305 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1712836 0.84 NR1H2 (0.40) NR1H2CYP3A4TSHRMAPK1L3MBTL1
SCHEMBL576260 0.84 MEN1 (0.48) MEN1KMT2AMAPTCYP1A2CYP2C9
SCHEMBL28256971 0.78 CA1 (0.42) CA1CA2CA7CA9ACHE
SCHEMBL5684842 0.78 GRM5 (0.36) NR1H2CYP3A4TSHRMAPK1MAOA
SCHEMBL5023998 0.77 MAOA (0.54) MAPTNR1H2CYP3A4TSHRMAPK1
SCHEMBL13837350 0.77 NR1H2 (0.38) MEN1KMT2AMAPTNR1H2CYP3A4
SCHEMBL5685309 0.76 HAO1 (0.45) MAOAMAOBACHE
SCHEMBL9686247 0.76 MAOA (0.35) MEN1KMT2AMAPTCYP1A2CYP2C9
SCHEMBL4115867 0.76 MEN1 (0.44) MEN1KMT2AMAPTCYP1A2CYP2C9
SCHEMBL3163844 0.75 MLYCD (0.44) MEN1KMT2AMAPTNR1H2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2013110313-A1 SELECTIVE ALLOSTERIC MODULATORS OF THE SEROTONIN TRANSPORTER H. LUNDBECK A/S (DK) 2013-08-01 WO claimed
WO-2013110313-A1 SELECTIVE ALLOSTERIC MODULATORS OF THE SEROTONIN TRANSPORTER H. LUNDBECK A/S (DK) 2013-08-01 WO disclosed
WO-2013110313-A1 SELECTIVE ALLOSTERIC MODULATORS OF THE SEROTONIN TRANSPORTER H. LUNDBECK A/S (DK) 2013-08-01 WO disclosed
US-20060122064-A1 Amides and method for plant diseases control with the same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2006-06-08 US disclosed
EP-1640360-A1 AMIDES AND METHOD FOR PLANT DISEASE CONTROL WITH THE SAME SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2006-03-29 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060122064-A1 Amides and method for plant diseases control with the same ARG1, ARGLU1, ARG2 MEN1 3091/4885KMT2A 1374/4885MAPT 3783/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.